From the Sector

The corona pandemic continues to put a strain on health systems around the globe. Many places lack effective textile protective kit among others for their medical personnel. HeiQ, a Swiss specialty chemicals company, has developed antiviral and antibacterial protective kit that is quickly effective against Coronaviruses (229E), as confirmed in wide-ranging studies. In cooperation with HeiQ, the CHT Group is supplying this technology to the market to help decrease the global shortage in protective wear.

A wide number of studies have proven that viruses and bacteria can remain active on textile surfaces for a longer period. The SARS-COV-2 virus, which causes the COVID-19 disease, can stay active on a textile for up to two days and therefore be infectious. Shortages in textile protective kit create a high risk for medical personnel who are in contact with COVID-19 patients: often, doctors and nurses cannot change their protective masks and clothing as frequently as would be necessary in order to adhere to hygiene rules and to prevent the spreading of the virus.

The HeiQ Viroblock NPJ03 that has been developed by HeiQ is a new technology that is also effective against Coronaviruses (229E) thanks to its antibacterial and antiviral properties. Comprehensive studies have demonstrated the kit‘s effectiveness. A combination of silver salts with a vesicle technology deactivates bacteria and viruses on textile surfaces within a few minutes and renders the bacteria and viruses harmless. Textiles equipped in this way reduce the rate of infection by 99.99%, which stops the transmission and the spread of bacteria and viruses through textiles.

Viroblock can be used on all types of fibers – not only for protective kit and masks, but also for work clothing, bed linen, towels and home textiles. The kit is wash-resistant and still highly effective after 30 standard wash processes.

Materials for in excess of one million protective masks
Within the context of supporting the critical infrastructure in Germany, Oerlikon Nonwoven immediately began converting its laboratory systems in Neumünster to manufacture nonwovens at the end of March. With this, only small local businesses and companies were initially supported in the manufacture of oronasal masks.
With the laboratory system at the R&D Center material for more than one million protective masks a month can be manufactured.

The laboratory has meanwhile run out of raw materials and new orders for replacement materials had to be placed before Easter – with current delivery times of approx. 3 weeks. This will allow production to be resumed, and even considerably expanded, in May.
The laboratory system is now once again being deployed to produce nonwovens that will be used to make more than million face masks / oronasal masks a month. “We will not be manufacturing the masks ourselves. We have meanwhile found both corresponding partner companies and also private individuals demanding nonwovens”, adds Andreas Frisch, commenting on the developments.

Boom in orders
Furthermore, Oerlikon Nonwoven has also fired up the production of the machines and systems used for its meltblown technology. The demand from Germany, Europe and the rest of the world has quickly
secured the company a high in orders..
We will be commissioning the first meltblown system at the site of a leading Western European nonwovens producers in the second quarter of 2020. The capacities for respiratory masks available in Europe to date are predominantly manufactured on Oerlikon
Nonwoven systems.

• The PREMIUM GROUP in Berlin is cancelling its PREMIUM and SEEK trade shows for this summer season, as well as the FASHIONTECH conference – in collaboration with the leading global digital B2B marketplace, JOOR, there is still a guaranteed trading option.

Due to the coronavirus crisis, in April the dates of the PREMIUM GROUP’s events were provisionally moved from the original schedule of 31 June-2 July 2020 to 28 -30 July. Now, the Federal and State governments have decided to cancel large-scale events with over 1,000 visitors until 31 August 2020.
     
A statement from Anita Tillmann, Managing Partner of the PREMIUM GROUP: 

“We greatly regret the decision of course, especially after the success of our January events. The ban on large-scale events has been around for some time and has been publicly discussed. It hurts us to do it, but we are also conscious of our responsibility. If cancelling our trade shows, conferences and parties contributes to the safety of our customers and visitors, then we have to take this step.
 
We are in close contact with all our brands and partners and have spent the last four weeks discussing possible approaches, concepts and new focal topics for the summer. The bottom line is that digitalisation is clearly the focus. It’s all about using the time over the next few months sensibly. The timing for brands and retailers is now right – all market participants are aware of the necessity of this.

We have been working closely with JOOR, the leading B2B marketplace globally, for around a year, after successfully integrating our own digital platform, Veee.com. JOOR has digitalised the entire procurement process and ensures a seamless, functioning wholesale process on an international scale – both for brands and retailers.
 
We shall shortly be offering webinars on this and can offer our customers an optimal, digital ordering solution so as to use this time of the pandemic efficiently. We are very happy with this option and our year-long investment in the topic of digitalisation. This has come good for us now.
 
Our trade show formats have been about more than just ordering for a long time now. They are about encounters, emotion, inspiration, communication and, finally, the fashion community getting together. Although lots can take place digitally nowadays, it doesn't replace physically meeting up in person. We have seen this more than ever in the present situation.
 
We are going to work on new concepts for 2021, and we will liaise with the key stakeholders in Berlin and with all others too to ensure we hit the ground running again. We’re taking on the challenge and will come back to the industry when we have news.”

Fairfield Chair Co. has retooled its production of chairs and sofas to high-in-demand surgical gowns in an effort to help rush supplies to health care companies on the frontline of the COVID-19 pandemic.

When the spread of the coronavirus impacted Fairfield and the entire U.S. manufacturing sector, Fairfield executives jumped into action.

The seating manufacturer, which essentially took a crash course on apparel patternmaking and industry specs, has switched its production to surgical gowns overnight. In just over a week, Fairfield produced its first samples of the surgical gown and immediately received approval on the prototype from Blue Ridge Healthcare in North Carolina, which has placed an initial order for 1,200 surgical gowns.
Cotswold Industries worked closely with Fairfield to help the company pivot to gown and mask manufacturing and provide the materials needed for the finished products.

Fairfield is also tapping into the experience it gained from producing seating for senior living facilities, which require certain materials with antimicrobial finishes.
“We are very accustomed to working with antimicrobial fabrics however, we have never worked with wovens that are developed to meet specifications like this material has to,” states McClurd, vice President of imports of Fairfield.

Brown Wrote to President Outlining Critical Steps White House can Take Now to Address Shortage of Personal Protective Equipment

 U.S. Sen. Sherrod Brown (D-OH) hosted a news conference call to discuss his plan for addressing the shortage of personal protective equipment (PPE) needed by healthcare workers on the frontline of keeping Americans healthy and safe during the coronavirus pandemic.

This weekend, Brown wrote to President Trump outlining several steps the Administration should take immediately to address the shortage and ramp up manufacturing of these critical medical supplies.

In his plan and in his letter to the President, Brown lists nine steps the Administration could take immediately, including:

1. Designate a government official who can serve as a point person responsible for coordination the acquisition and development of PPE, medical devices, and other supplies necessary to fight the coronavirus pandemic. 
2. Establish a PPE and medical device assessment and database to monitor the supply and anticipated needs for PPE, ventilators, diagnostic test kits, and other needed medical supplies to respond to the coronavirus pandemic. 
3. Publish a list of PPE, medical device, and general medical supply needs to respond to the coronavirus pandemic. 
4. Establish a hotline capable of handling significant call capacity that will provide U.S. producers centralized information about the results of the national assessment and the current need for PPE, devices, and other health care supplies. 
5. Provide immediate funding to manufacturers to purchase equipment, retool machinery, hire additional workers, and cover any other expenses needed to increase production of PPE and necessary medical devices and supplies.
6. Streamline contract and certification procedures to ensure production and delivery of materials are not delayed due to paperwork constraints.
7. Provide critical protections for workers who are making PPE, medical devices, and necessary supplies to receive a waiver from any shelter-in-place requirements to allow workers to volunteer to go to work in these critical industries. 
8. Provide purchase guarantees and delivery assistance of product to the communities and health care facilities that need the products most. 
9. Support companies that have the capacity to sterilize reusable equipment to alleviate the existing PPE shortage. 

In his plan, Brown also pointed out important legislative actions that will help ramp up production of these critical supplies, including expanding the strategic national stockpile authority, substantially increasing Defense Production Act funding and strengthening domestic preferences.

Textile and nonwoven associations issued a joint statement today urging federal, state and local governments to deem textile and nonwoven manufacturing facilities as “essential” when drafting “Shelter in Place” orders in response to the COVID-19 crisis.

Our associations recognize the serious challenges our elected officials, health administrators, and others are facing when issuing orders to protect communities across the country and we understand the necessity for leaders to enforce a ‘Shelter in Place” order or quarantine orders.

Our members make a broad range of inputs and finished products used in an array of personal protective equipment (PPE) and medical nonwoven/textile supplies, including surgical gowns, face masks, antibacterial wipes, lab coats, blood pressure cuffs, cotton swabs and hazmat suits. These items are vital to the government’s effort to ramp up emergency production of these critical supplies.

If workers who produce these goods are not granted an “essential” exemption from “Shelter in Place” and other quarantine orders to go to their manufacturing and distribution facilities, it will cause major disruptions in the availability of these goods. This will create significant hardship to healthcare providers and consumers across the country who depend on steady and stable supplies of these critical items.

We are asking the administration and state and local authorities to provide greater certainty and clarity for our companies and employees and ask for a clear exclusion of our manufacturing operations from “Shelter in Place” orders as the textile and nonwoven products that we make in the U.S. play an essential role in mitigating the shortages of critical supplies. Such a designation will help us avoid disruptions of vital goods and services during this challenging time.